Latest News about APLS
Recent news which mentions APLS
Mid-Afternoon Market Update: Dow Slides Over 100 Points; Echo Global Logistics Shares Spike Higher
September 10, 2021
From Benzinga
What 11 Analyst Ratings Have To Say About Apellis Pharmaceuticals
September 10, 2021
Tickers
APLS
From Benzinga
8 Health Care Stocks With Unusual Options Alerts In Today's Session
September 10, 2021
From Benzinga
Tickers
APLS
From InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
September 10, 2021
From Benzinga
Mid-Day Market Update: Crude Oil Rises Over 2%; Apellis Pharmaceuticals Shares Plunge
September 10, 2021
From Benzinga
41 Stocks Moving In Friday's Mid-Day Session
September 10, 2021
From Benzinga
Here's Why Iveric Bio Stock Is Rocketing Higher Today
September 10, 2021
From Motley Fool
ISEE Stock: Why Rival Eye Drug Developer’s Disappointment Is a Boon to IVERIC bio
September 10, 2021
From InvestorPlace
Here's Why Apellis Pharmaceuticals Is Getting Hammered Today
September 10, 2021
Tickers
APLS
From Motley Fool
Why IVERIC Bio Shares Are Soaring Today
September 10, 2021
From Benzinga
Mid-Morning Market Update: Markets Mixed; Kroger Tops Q2 Views
September 10, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021
September 10, 2021
From Benzinga
10 Biggest Price Target Changes For Friday
September 10, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 10, 2021
From Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 10, 2021
From InvestorPlace
20 Stocks Moving in Friday's Pre-Market Session
September 10, 2021
From Benzinga
Apellis Unveils Mixed Results For Eye Disorder Drug, But Still Hopes To Pass FDA Finish Line
September 10, 2021
Tickers
APLS
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2021
August 19, 2021
From Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
From Benzinga
10 Biggest Price Target Changes For Thursday
July 08, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|